img

Influenza Vaccines


Published on: 2024-01-04 | No of Pages : 127 | Industry : Pharma & Healthcare

Publisher : HNY Research | Format : PDF&Excel

Influenza Vaccines

The global Influenza Vaccines market was valued at 3453.47 Million USD in 2021 and will grow with a CAGR of 4.54% from 2021 to 2027, based on HNY Research newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. The CDC estimates that vaccination against influenza reduces sickness, medical visits, hospitalizations, and deaths. When an immunized worker does catch the flu, they are on average back at work a half day sooner. Vaccine effectiveness in those under two years old and over 65 years old remains unknown due to the low quality of the research. needs update][8][needs update] Vaccinating children may protect those around them. The World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) recommend yearly vaccination for nearly all people over the age of six months, especially those at high risk. The European Centre for Disease Prevention and Control also recommends yearly vaccination of high risk groups. These groups include pregnant women, the elderly, children between six months and five years of age, those with other health problems, and those who work in healthcare. The vaccines are generally safe. Fever occurs in five to ten percent of children vaccinated. Temporary muscle pains or feelings of tiredness may occur as well. In certain years, the vaccine has been linked to an increase in Guillain-Barré syndrome among older people at a rate of about one case per million doses. It should not be given to those with severe allergies to eggs or to previous versions of the vaccine. The vaccines come in both inactive and weakened viral forms. The inactive version should be used for those who are pregnant. They come in forms that are injected into a muscle, sprayed into the nose, or injected into the middle layer of the skin. Vaccination against influenza began in the 1930s with large scale availability in the United States beginning in 1945. It is on the World Health Organization`s List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale price in the developing world is about $5.25 USD per dose as of 2014.In the United States, it costs less than $25 USD as of 2015.

By Market Verdors

AstraZeneca

CSL

GlaxoSmithKline

Sanofi

Altimmune

BionVax

FluGen

FOLIA BIOTECH

Genentech

Green Cross

Medicago

Moderna Therapeutics

Novavax

Shijiazhuang Yiling Pharmaceutical

SK Chemicals

UNM Pharma

Vaccitech

Vaxart

Vaxine Pty

Visterra



By Types

Trivalent Flu Vaccines

Quadrivalent Flu Vaccines



By Applications

Adults

Pediatrics



Key Indicators Analysed

Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.

Opportunities and DriversIdentifying the Growing Demands and New Technology

Porters Five Force AnalysisThe report provides with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.



Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements

Table of Content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered: Ranking by Influenza Vaccines Revenue

1.4 Market Analysis by Type

1.4.1 Global Influenza Vaccines Market Size Growth Rate by Type: 2021 VS 2027

1.4.2 Trivalent Flu Vaccines

1.4.3 Quadrivalent Flu Vaccines

1.5 Market by Application

1.5.1 Global Influenza Vaccines Market Share by Application: 2022-2027

1.5.2 Adults

1.5.3 Pediatrics

1.6 Study Objectives

1.7 Years Considered

1.8 Overview of Global Influenza Vaccines Market

1.8.1 Global Influenza Vaccines Market Status and Outlook (2016-2027)

1.8.2 North America

1.8.3 East Asia

1.8.4 Europe

1.8.5 South Asia

1.8.6 Southeast Asia

1.8.7 Middle East

1.8.8 Africa

1.8.9 Oceania

1.8.10 South America

1.8.11 Rest of the World

2 Market Competition by Manufacturers

2.1 Global Influenza Vaccines Production Capacity Market Share by Manufacturers (2016-2021)

2.2 Global Influenza Vaccines Revenue Market Share by Manufacturers (2016-2021)

2.3 Global Influenza Vaccines Average Price by Manufacturers (2016-2021)

2.4 Manufacturers Influenza Vaccines Production Sites, Area Served, Product Type

3 Sales by Region

3.1 Global Influenza Vaccines Sales Volume Market Share by Region (2016-2021)

3.2 Global Influenza Vaccines Sales Revenue Market Share by Region (2016-2021)

3.3 North America Influenza Vaccines Sales Volume

3.3.1 North America Influenza Vaccines Sales Volume Growth Rate (2016-2021)

3.3.2 North America Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 East Asia Influenza Vaccines Sales Volume

3.4.1 East Asia Influenza Vaccines Sales Volume Growth Rate (2016-2021)

3.4.2 East Asia Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Europe Influenza Vaccines Sales Volume (2016-2021)

3.5.1 Europe Influenza Vaccines Sales Volume Growth Rate (2016-2021)

3.5.2 Europe Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 South Asia Influenza Vaccines Sales Volume (2016-2021)

3.6.1 South Asia Influenza Vaccines Sales Volume Growth Rate (2016-2021)

3.6.2 South Asia Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 Southeast Asia Influenza Vaccines Sales Volume (2016-2021)

3.7.1 Southeast Asia Influenza Vaccines Sales Volume Growth Rate (2016-2021)

3.7.2 Southeast Asia Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Middle East Influenza Vaccines Sales Volume (2016-2021)

3.8.1 Middle East Influenza Vaccines Sales Volume Growth Rate (2016-2021)

3.8.2 Middle East Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 Africa Influenza Vaccines Sales Volume (2016-2021)

3.9.1 Africa Influenza Vaccines Sales Volume Growth Rate (2016-2021)

3.9.2 Africa Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 Oceania Influenza Vaccines Sales Volume (2016-2021)

3.10.1 Oceania Influenza Vaccines Sales Volume Growth Rate (2016-2021)

3.10.2 Oceania Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.11 South America Influenza Vaccines Sales Volume (2016-2021)

3.11.1 South America Influenza Vaccines Sales Volume Growth Rate (2016-2021)

3.11.2 South America Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.12 Rest of the World Influenza Vaccines Sales Volume (2016-2021)

3.12.1 Rest of the World Influenza Vaccines Sales Volume Growth Rate (2016-2021)

3.12.2 Rest of the World Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

4 North America

4.1 North America Influenza Vaccines Consumption by Countries

4.2 United States

4.3 Canada

4.4 Mexico

5 East Asia

5.1 East Asia Influenza Vaccines Consumption by Countries

5.2 China

5.3 Japan

5.4 South Korea

6 Europe

6.1 Europe Influenza Vaccines Consumption by Countries

6.2 Germany

6.3 United Kingdom

6.4 France

6.5 Italy

6.6 Russia

6.7 Spain

6.8 Netherlands

6.9 Switzerland

6.10 Poland

7 South Asia

7.1 South Asia Influenza Vaccines Consumption by Countries

7.2 India

7.3 Pakistan

7.4 Bangladesh

8 Southeast Asia

8.1 Southeast Asia Influenza Vaccines Consumption by Countries

8.2 Indonesia

8.3 Thailand

8.4 Singapore

8.5 Malaysia

8.6 Philippines

8.7 Vietnam

8.8 Myanmar

9 Middle East

9.1 Middle East Influenza Vaccines Consumption by Countries

9.2 Turkey

9.3 Saudi Arabia

9.4 Iran

9.5 United Arab Emirates

9.6 Israel

9.7 Iraq

9.8 Qatar

9.9 Kuwait

9.10 Oman

10 Africa

10.1 Africa Influenza Vaccines Consumption by Countries

10.2 Nigeria

10.3 South Africa

10.4 Egypt

10.5 Algeria

10.6 Morocco

11 Oceania

11.1 Oceania Influenza Vaccines Consumption by Countries

11.2 Australia

11.3 New Zealand

12 South America

12.1 South America Influenza Vaccines Consumption by Countries

12.2 Brazil

12.3 Argentina

12.4 Columbia

12.5 Chile

12.6 Venezuela

12.7 Peru

12.8 Puerto Rico

12.9 Ecuador

13 Rest of the World

13.1 Rest of the World Influenza Vaccines Consumption by Countries

13.2 Kazakhstan

14 Sales Volume, Sales Revenue, Sales Price Trend by Type

14.1 Global Influenza Vaccines Sales Volume Market Share by Type (2016-2021)

14.2 Global Influenza Vaccines Sales Revenue Market Share by Type (2016-2021)

14.3 Global Influenza Vaccines Sales Price by Type (2016-2021)

15 Consumption Analysis by Application

15.1 Global Influenza Vaccines Consumption Volume by Application (2016-2021)

15.2 Global Influenza Vaccines Consumption Value by Application (2016-2021)

16 Company Profiles and Key Figures in Influenza Vaccines Business

16.1 AstraZeneca

16.1.1 AstraZeneca Company Profile

16.1.2 AstraZeneca Influenza Vaccines Product Specification

16.1.3 AstraZeneca Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.2 CSL

16.2.1 CSL Company Profile

16.2.2 CSL Influenza Vaccines Product Specification

16.2.3 CSL Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.3 GlaxoSmithKline

16.3.1 GlaxoSmithKline Company Profile

16.3.2 GlaxoSmithKline Influenza Vaccines Product Specification

16.3.3 GlaxoSmithKline Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.4 Sanofi

16.4.1 Sanofi Company Profile

16.4.2 Sanofi Influenza Vaccines Product Specification

16.4.3 Sanofi Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.5 Altimmune

16.5.1 Altimmune Company Profile

16.5.2 Altimmune Influenza Vaccines Product Specification

16.5.3 Altimmune Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.6 BionVax

16.6.1 BionVax Company Profile

16.6.2 BionVax Influenza Vaccines Product Specification

16.6.3 BionVax Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.7 FluGen

16.7.1 FluGen Company Profile

16.7.2 FluGen Influenza Vaccines Product Specification

16.7.3 FluGen Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.8 FOLIA BIOTECH

16.8.1 FOLIA BIOTECH Company Profile

16.8.2 FOLIA BIOTECH Influenza Vaccines Product Specification

16.8.3 FOLIA BIOTECH Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.9 Genentech

16.9.1 Genentech Company Profile

16.9.2 Genentech Influenza Vaccines Product Specification

16.9.3 Genentech Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.10 Green Cross

16.10.1 Green Cross Company Profile

16.10.2 Green Cross Influenza Vaccines Product Specification

16.10.3 Green Cross Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.11 Medicago

16.11.1 Medicago Company Profile

16.11.2 Medicago Influenza Vaccines Product Specification

16.11.3 Medicago Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.12 Moderna Therapeutics

16.12.1 Moderna Therapeutics Company Profile

16.12.2 Moderna Therapeutics Influenza Vaccines Product Specification

16.12.3 Moderna Therapeutics Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.13 Novavax

16.13.1 Novavax Company Profile

16.13.2 Novavax Influenza Vaccines Product Specification

16.13.3 Novavax Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.14 Shijiazhuang Yiling Pharmaceutical

16.14.1 Shijiazhuang Yiling Pharmaceutical Company Profile

16.14.2 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Product Specification

16.14.3 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.15 SK Chemicals

16.15.1 SK Chemicals Company Profile

16.15.2 SK Chemicals Influenza Vaccines Product Specification

16.15.3 SK Chemicals Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.16 UNM Pharma

16.16.1 UNM Pharma Company Profile

16.16.2 UNM Pharma Influenza Vaccines Product Specification

16.16.3 UNM Pharma Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.17 Vaccitech

16.17.1 Vaccitech Company Profile

16.17.2 Vaccitech Influenza Vaccines Product Specification

16.17.3 Vaccitech Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.18 Vaxart

16.18.1 Vaxart Company Profile

16.18.2 Vaxart Influenza Vaccines Product Specification

16.18.3 Vaxart Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.19 Vaxine Pty

16.19.1 Vaxine Pty Company Profile

16.19.2 Vaxine Pty Influenza Vaccines Product Specification

16.19.3 Vaxine Pty Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.20 Visterra

16.20.1 Visterra Company Profile

16.20.2 Visterra Influenza Vaccines Product Specification

16.20.3 Visterra Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

17 Influenza Vaccines Manufacturing Cost Analysis

17.1 Influenza Vaccines Key Raw Materials Analysis

17.1.1 Key Raw Materials

17.2 Proportion of Manufacturing Cost Structure

17.3 Manufacturing Process Analysis of Influenza Vaccines

17.4 Influenza Vaccines Industrial Chain Analysis

18 Marketing Channel, Distributors and Customers

18.1 Marketing Channel

18.2 Influenza Vaccines Distributors List

18.3 Influenza Vaccines Customers

19 Market Dynamics

19.1 Market Trends

19.2 Opportunities and Drivers

19.3 Challenges

19.4 Porter's Five Forces Analysis

20 Production and Supply Forecast

20.1 Global Forecasted Production of Influenza Vaccines (2022-2027)

20.2 Global Forecasted Revenue of Influenza Vaccines (2022-2027)

20.3 Global Forecasted Price of Influenza Vaccines (2016-2027)

20.4 Global Forecasted Production of Influenza Vaccines by Region (2022-2027)

20.4.1 North America Influenza Vaccines Production, Revenue Forecast (2022-2027)

20.4.2 East Asia Influenza Vaccines Production, Revenue Forecast (2022-2027)

20.4.3 Europe Influenza Vaccines Production, Revenue Forecast (2022-2027)

20.4.4 South Asia Influenza Vaccines Production, Revenue Forecast (2022-2027)

20.4.5 Southeast Asia Influenza Vaccines Production, Revenue Forecast (2022-2027)

20.4.6 Middle East Influenza Vaccines Production, Revenue Forecast (2022-2027)

20.4.7 Africa Influenza Vaccines Production, Revenue Forecast (2022-2027)

20.4.8 Oceania Influenza Vaccines Production, Revenue Forecast (2022-2027)

20.4.9 South America Influenza Vaccines Production, Revenue Forecast (2022-2027)

20.4.10 Rest of the World Influenza Vaccines Production, Revenue Forecast (2022-2027)

20.5 Forecast by Type and by Application (2022-2027)

20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

20.5.2 Global Forecasted Consumption of Influenza Vaccines by Application (2022-2027)

21 Consumption and Demand Forecast

21.1 North America Forecasted Consumption of Influenza Vaccines by Country

21.2 East Asia Market Forecasted Consumption of Influenza Vaccines by Country

21.3 Europe Market Forecasted Consumption of Influenza Vaccines by Countriy

21.4 South Asia Forecasted Consumption of Influenza Vaccines by Country

21.5 Southeast Asia Forecasted Consumption of Influenza Vaccines by Country

21.6 Middle East Forecasted Consumption of Influenza Vaccines by Country

21.7 Africa Forecasted Consumption of Influenza Vaccines by Country

21.8 Oceania Forecasted Consumption of Influenza Vaccines by Country

21.9 South America Forecasted Consumption of Influenza Vaccines by Country

21.10 Rest of the world Forecasted Consumption of Influenza Vaccines by Country

22 Research Findings and Conclusion

23 Methodology and Data Source

23.1 Methodology/Research Approach

23.1.1 Research Programs/Design

23.1.2 Market Size Estimation

23.1.3 Market Breakdown and Data Triangulation

23.2 Data Source

23.2.1 Secondary Sources

23.2.2 Primary Sources

23.3 Disclaimer



List of Figure

Key Players Covered: Ranking by Influenza Vaccines Revenue (US$ Million) 2016-2021

Global Influenza Vaccines Market Size by Type (US$ Million): 2022-2027

Global Influenza Vaccines Market Size by Application (US$ Million): 2022-2027

Global Influenza Vaccines Production Capacity by Manufacturers

Global Influenza Vaccines Production by Manufacturers (2016-2021)

Global Influenza Vaccines Production Market Share by Manufacturers (2016-2021)

Global Influenza Vaccines Revenue by Manufacturers (2016-2021)

Global Influenza Vaccines Revenue Share by Manufacturers (2016-2021)

Global Market Influenza Vaccines Average Price of Key Manufacturers (2016-2021)

Manufacturers Influenza Vaccines Production Sites and Area Served

Manufacturers Influenza Vaccines Product Type

Global Influenza Vaccines Sales Volume by Region (2016-2021)

Global Influenza Vaccines Sales Volume Market Share by Region (2016-2021)

Global Influenza Vaccines Sales Revenue by Region (2016-2021)

Global Influenza Vaccines Sales Revenue Market Share by Region (2016-2021)

North America Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

East Asia Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Europe Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

South Asia Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Southeast Asia Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Middle East Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Africa Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Oceania Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

South America Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Rest of the World Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

North America Influenza Vaccines Consumption by Countries (2016-2021)

East Asia Influenza Vaccines Consumption by Countries (2016-2021)

Europe Influenza Vaccines Consumption by Region (2016-2021)

South Asia Influenza Vaccines Consumption by Countries (2016-2021)

Southeast Asia Influenza Vaccines Consumption by Countries (2016-2021)

Middle East Influenza Vaccines Consumption by Countries (2016-2021)

Africa Influenza Vaccines Consumption by Countries (2016-2021)

Oceania Influenza Vaccines Consumption by Countries (2016-2021)

South America Influenza Vaccines Consumption by Countries (2016-2021)

Rest of the World Influenza Vaccines Consumption by Countries (2016-2021)

Global Influenza Vaccines Sales Volume by Type (2016-2021)

Global Influenza Vaccines Sales Volume Market Share by Type (2016-2021)

Global Influenza Vaccines Sales Revenue by Type (2016-2021)

Global Influenza Vaccines Sales Revenue Share by Type (2016-2021)

Global Influenza Vaccines Sales Price by Type (2016-2021)

Global Influenza Vaccines Consumption Volume by Application (2016-2021)

Global Influenza Vaccines Consumption Volume Market Share by Application (2016-2021)

Global Influenza Vaccines Consumption Value by Application (2016-2021)

Global Influenza Vaccines Consumption Value Market Share by Application (2016-2021)

AstraZeneca Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

CSL Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

GlaxoSmithKline Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table Sanofi Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Altimmune Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

BionVax Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

FluGen Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

FOLIA BIOTECH Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Genentech Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Green Cross Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Medicago Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Moderna Therapeutics Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Novavax Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

SK Chemicals Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

UNM Pharma Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Vaccitech Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Vaxart Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Vaxine Pty Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Visterra Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Influenza Vaccines Distributors List

Influenza Vaccines Customers List

Market Key Trends

Key Opportunities and Drivers: Impact Analysis (2022-2027)

Key Challenges

Global Influenza Vaccines Production Forecast by Region (2022-2027)

Global Influenza Vaccines Sales Volume Forecast by Type (2022-2027)

Global Influenza Vaccines Sales Volume Market Share Forecast by Type (2022-2027)

Global Influenza Vaccines Sales Revenue Forecast by Type (2022-2027)

Global Influenza Vaccines Sales Revenue Market Share Forecast by Type (2022-2027)

Global Influenza Vaccines Sales Price Forecast by Type (2022-2027)

Global Influenza Vaccines Consumption Volume Forecast by Application (2022-2027)

Global Influenza Vaccines Consumption Value Forecast by Application (2022-2027)

North America Influenza Vaccines Consumption Forecast 2022-2027 by Country

East Asia Influenza Vaccines Consumption Forecast 2022-2027 by Country

Europe Influenza Vaccines Consumption Forecast 2022-2027 by Country

South Asia Influenza Vaccines Consumption Forecast 2022-2027 by Country

Southeast Asia Influenza Vaccines Consumption Forecast 2022-2027 by Country

Middle East Influenza Vaccines Consumption Forecast 2022-2027 by Country

Africa Influenza Vaccines Consumption Forecast 2022-2027 by Country

Oceania Influenza Vaccines Consumption Forecast 2022-2027 by Country

South America Influenza Vaccines Consumption Forecast 2022-2027 by Country

Rest of the world Influenza Vaccines Consumption Forecast 2022-2027 by Country

Research Programs/Design for This Report

Key Data Information from Secondary Sources

Key Data Information from Primary Sources





Global Influenza Vaccines Market Share by Type: 2021 VS 2027

Trivalent Flu Vaccines Features

Quadrivalent Flu Vaccines Features

Global Influenza Vaccines Market Share by Application: 2021 VS 2027

Adults Case Studies

Pediatrics Case Studies

Influenza Vaccines Report Years Considered

Global Influenza Vaccines Market Status and Outlook (2016-2027)

North America Influenza Vaccines Revenue (Value) and Growth Rate (2016-2027)

East Asia Influenza Vaccines Revenue (Value) and Growth Rate (2016-2027)

Europe Influenza Vaccines Revenue (Value) and Growth Rate (2016-2027)

South Asia Influenza Vaccines Revenue (Value) and Growth Rate (2016-2027)

South America Influenza Vaccines Revenue (Value) and Growth Rate (2016-2027)

Middle East Influenza Vaccines Revenue (Value) and Growth Rate (2016-2027)

Africa Influenza Vaccines Revenue (Value) and Growth Rate (2016-2027)

Oceania Influenza Vaccines Revenue (Value) and Growth Rate (2016-2027)

South America Influenza Vaccines Revenue (Value) and Growth Rate (2016-2027)

Rest of the World Influenza Vaccines Revenue (Value) and Growth Rate (2016-2027)

North America Influenza Vaccines Sales Volume Growth Rate (2016-2021)

East Asia Influenza Vaccines Sales Volume Growth Rate (2016-2021)

Europe Influenza Vaccines Sales Volume Growth Rate (2016-2021)

South Asia Influenza Vaccines Sales Volume Growth Rate (2016-2021)

Southeast Asia Influenza Vaccines Sales Volume Growth Rate (2016-2021)

Middle East Influenza Vaccines Sales Volume Growth Rate (2016-2021)

Africa Influenza Vaccines Sales Volume Growth Rate (2016-2021)

Oceania Influenza Vaccines Sales Volume Growth Rate (2016-2021)

South America Influenza Vaccines Sales Volume Growth Rate (2016-2021)

Rest of the World Influenza Vaccines Sales Volume Growth Rate (2016-2021)

North America Influenza Vaccines Consumption and Growth Rate (2016-2021)

North America Influenza Vaccines Consumption Market Share by Countries in 2021

United States Influenza Vaccines Consumption and Growth Rate (2016-2021)

Canada Influenza Vaccines Consumption and Growth Rate (2016-2021)

Mexico Influenza Vaccines Consumption and Growth Rate (2016-2021)

East Asia Influenza Vaccines Consumption and Growth Rate (2016-2021)

East Asia Influenza Vaccines Consumption Market Share by Countries in 2021

China Influenza Vaccines Consumption and Growth Rate (2016-2021)

Japan Influenza Vaccines Consumption and Growth Rate (2016-2021)

South Korea Influenza Vaccines Consumption and Growth Rate (2016-2021)

Europe Influenza Vaccines Consumption and Growth Rate

Europe Influenza Vaccines Consumption Market Share by Region in 2021

Germany Influenza Vaccines Consumption and Growth Rate (2016-2021)

United Kingdom Influenza Vaccines Consumption and Growth Rate (2016-2021)

France Influenza Vaccines Consumption and Growth Rate (2016-2021)

Italy Influenza Vaccines Consumption and Growth Rate (2016-2021)

Russia Influenza Vaccines Consumption and Growth Rate (2016-2021)

Spain Influenza Vaccines Consumption and Growth Rate (2016-2021)

Netherlands Influenza Vaccines Consumption and Growth Rate (2016-2021)

Switzerland Influenza Vaccines Consumption and Growth Rate (2016-2021)

Poland Influenza Vaccines Consumption and Growth Rate (2016-2021)

South Asia Influenza Vaccines Consumption and Growth Rate

South Asia Influenza Vaccines Consumption Market Share by Countries in 2021

India Influenza Vaccines Consumption and Growth Rate (2016-2021)

Pakistan Influenza Vaccines Consumption and Growth Rate (2016-2021)

Bangladesh Influenza Vaccines Consumption and Growth Rate (2016-2021)

Southeast Asia Influenza Vaccines Consumption and Growth Rate

Southeast Asia Influenza Vaccines Consumption Market Share by Countries in 2021

Indonesia Influenza Vaccines Consumption and Growth Rate (2016-2021)

Thailand Influenza Vaccines Consumption and Growth Rate (2016-2021)

Singapore Influenza Vaccines Consumption and Growth Rate (2016-2021)

Malaysia Influenza Vaccines Consumption and Growth Rate (2016-2021)

Philippines Influenza Vaccines Consumption and Growth Rate (2016-2021)

Vietnam Influenza Vaccines Consumption and Growth Rate (2016-2021)

Myanmar Influenza Vaccines Consumption and Growth Rate (2016-2021)

Middle East Influenza Vaccines Consumption and Growth Rate

Middle East Influenza Vaccines Consumption Market Share by Countries in 2021

Turkey Influenza Vaccines Consumption and Growth Rate (2016-2021)

Saudi Arabia Influenza Vaccines Consumption and Growth Rate (2016-2021)

Iran Influenza Vaccines Consumption and Growth Rate (2016-2021)

United Arab Emirates Influenza Vaccines Consumption and Growth Rate (2016-2021)

Israel Influenza Vaccines Consumption and Growth Rate (2016-2021)

Iraq Influenza Vaccines Consumption and Growth Rate (2016-2021)

Qatar Influenza Vaccines Consumption and Growth Rate (2016-2021)

Kuwait Influenza Vaccines Consumption and Growth Rate (2016-2021)

Oman Influenza Vaccines Consumption and Growth Rate (2016-2021)

Africa Influenza Vaccines Consumption and Growth Rate

Africa Influenza Vaccines Consumption Market Share by Countries in 2021

Nigeria Influenza Vaccines Consumption and Growth Rate (2016-2021)

South Africa Influenza Vaccines Consumption and Growth Rate (2016-2021)

Egypt Influenza Vaccines Consumption and Growth Rate (2016-2021)

Algeria Influenza Vaccines Consumption and Growth Rate (2016-2021)

Morocco Influenza Vaccines Consumption and Growth Rate (2016-2021)

Oceania Influenza Vaccines Consumption and Growth Rate

Oceania Influenza Vaccines Consumption Market Share by Countries in 2021

Australia Influenza Vaccines Consumption and Growth Rate (2016-2021)

New Zealand Influenza Vaccines Consumption and Growth Rate (2016-2021)

South America Influenza Vaccines Consumption and Growth Rate

South America Influenza Vaccines Consumption Market Share by Countries in 2021

Brazil Influenza Vaccines Consumption and Growth Rate (2016-2021)

Argentina Influenza Vaccines Consumption and Growth Rate (2016-2021)

Columbia Influenza Vaccines Consumption and Growth Rate (2016-2021)

Chile Influenza Vaccines Consumption and Growth Rate (2016-2021)

Venezuelal Influenza Vaccines Consumption and Growth Rate (2016-2021)

Peru Influenza Vaccines Consumption and Growth Rate (2016-2021)

Puerto Rico Influenza Vaccines Consumption and Growth Rate (2016-2021)

Ecuador Influenza Vaccines Consumption and Growth Rate (2016-2021)

Rest of the World Influenza Vaccines Consumption and Growth Rate

Rest of the World Influenza Vaccines Consumption Market Share by Countries in 2021

Kazakhstan Influenza Vaccines Consumption and Growth Rate (2016-2021)

Sales Market Share of Influenza Vaccines by Type in 2021

Sales Revenue Market Share of Influenza Vaccines by Type in 2021

Global Influenza Vaccines Consumption Volume Market Share by Application in 2021

AstraZeneca Influenza Vaccines Product Specification

CSL Influenza Vaccines Product Specification

GlaxoSmithKline Influenza Vaccines Product Specification

Sanofi Influenza Vaccines Product Specification

Altimmune Influenza Vaccines Product Specification

BionVax Influenza Vaccines Product Specification

FluGen Influenza Vaccines Product Specification

FOLIA BIOTECH Influenza Vaccines Product Specification

Genentech Influenza Vaccines Product Specification

Green Cross Influenza Vaccines Product Specification

Medicago Influenza Vaccines Product Specification

Moderna Therapeutics Influenza Vaccines Product Specification

Novavax Influenza Vaccines Product Specification

Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Product Specification

SK Chemicals Influenza Vaccines Product Specification

UNM Pharma Influenza Vaccines Product Specification

Vaccitech Influenza Vaccines Product Specification

Vaxart Influenza Vaccines Product Specification

Vaxine Pty Influenza Vaccines Product Specification

Visterra Influenza Vaccines Product Specification

Manufacturing Cost Structure of Influenza Vaccines

Manufacturing Process Analysis of Influenza Vaccines

Influenza Vaccines Industrial Chain Analysis

Channels of Distribution

Distributors Profiles

Porter's Five Forces Analysis

Global Influenza Vaccines Production Capacity Growth Rate Forecast (2022-2027)

Global Influenza Vaccines Revenue Growth Rate Forecast (2022-2027)

Global Influenza Vaccines Price and Trend Forecast (2016-2027)

North America Influenza Vaccines Production Growth Rate Forecast (2022-2027)

North America Influenza Vaccines Revenue Growth Rate Forecast (2022-2027)

East Asia Influenza Vaccines Production Growth Rate Forecast (2022-2027)

East Asia Influenza Vaccines Revenue Growth Rate Forecast (2022-2027)

Europe Influenza Vaccines Production Growth Rate Forecast (2022-2027)

Europe Influenza Vaccines Revenue Growth Rate Forecast (2022-2027)

South Asia Influenza Vaccines Production Growth Rate Forecast (2022-2027)

South Asia Influenza Vaccines Revenue Growth Rate Forecast (2022-2027)

Southeast Asia Influenza Vaccines Production Growth Rate Forecast (2022-2027)

Southeast Asia Influenza Vaccines Revenue Growth Rate Forecast (2022-2027)

Middle East Influenza Vaccines Production Growth Rate Forecast (2022-2027)

Middle East Influenza Vaccines Revenue Growth Rate Forecast (2022-2027)

Africa Influenza Vaccines Production Growth Rate Forecast (2022-2027)

Africa Influenza Vaccines Revenue Growth Rate Forecast (2022-2027)

Oceania Influenza Vaccines Production Growth Rate Forecast (2022-2027)

Oceania Influenza Vaccines Revenue Growth Rate Forecast (2022-2027)

South America Influenza Vaccines Production Growth Rate Forecast (2022-2027)

South America Influenza Vaccines Revenue Growth Rate Forecast (2022-2027)

Rest of the World Influenza Vaccines Production Growth Rate Forecast (2022-2027)

Rest of the World Influenza Vaccines Revenue Growth Rate Forecast (2022-2027)

North America Influenza Vaccines Consumption Forecast 2022-2027

East Asia Influenza Vaccines Consumption Forecast 2022-2027

Europe Influenza Vaccines Consumption Forecast 2022-2027

South Asia Influenza Vaccines Consumption Forecast 2022-2027

Southeast Asia Influenza Vaccines Consumption Forecast 2022-2027

Middle East Influenza Vaccines Consumption Forecast 2022-2027

Africa Influenza Vaccines Consumption Forecast 2022-2027

Oceania Influenza Vaccines Consumption Forecast 2022-2027

South America Influenza Vaccines Consumption Forecast 2022-2027

Rest of the world Influenza Vaccines Consumption Forecast 2022-2027

Bottom-up and Top-down Approaches for This Report